11 Stocks With Significant Institutional And Insider Buying

 

4. Horizon Pharma, Inc. (HZNP): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $148.41M, most recent closing price at $2.41. Net institutional purchases in the current quarter at 22.6M shares, which represents about 54.03% of the company’s float of 41.83M shares. Over the last six months, insiders were net buyers of 575,356 shares, which represents about 1.38% of the company’s 41.83M share float.

 

5. Infinity Pharmaceuticals, Inc. (INFI): Engages in the discovery and development of medicines for the treatment of cancer and other conditions in the United States. Market cap at $1.04B, most recent closing price at $26.33. Net institutional purchases in the current quarter at 8.7M shares, which represents about 39.28% of the company’s float of 22.15M shares. Over the last six months, insiders were net buyers of 5,158,726 shares, which represents about 23.29% of the company’s 22.15M share float.

 

6. Molycorp, Inc. (MCP): Focuses on the production and sale of rare earth oxides from stockpiled feedstocks in the western hemisphere. Market cap at $1.52B, most recent closing price at $10.99. Net institutional purchases in the current quarter at 10.1M shares, which represents about 17.82% of the company’s float of 56.68M shares. Over the last six months, insiders were net buyers of 7,107,150 shares, which represents about 7.81% of the company’s 91.00M share float.

 

7. Nanosphere, Inc. (NSPH): Develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Market cap at $159.86M, most recent closing price at $2.85. Net institutional purchases in the current quarter at 4.9M shares, which represents about 12.34% of the company’s float of 39.72M shares. Over the last six months, insiders were net buyers of 1,924,100 shares, which represents about 4.84% of the company’s 39.72M share float.

BONUS: Significant short covering month-over-month:  Shares shorted have decreased from 3.11M to 1.56M over the last month, a decrease which represents about 3.9% of the company’s float of 39.72M shares. Days to cover ratio at 2.33 days.

« First ‹ Previous 1 2 3 4 5 Next › Last »